Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 7, 2017; 23(25): 4480-4490
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4480
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4480
Coregulator | CNV (%) | Expression | Ref. |
NCOA1 | Gain (5.5) | ND | |
NCOA2 | Gain (30.1) | ↑ or ↓ | Giannini 2005, Grivas 2009, Yu 2016 |
NCOA3 | Gain (40.6) | ↑ | Anzick 1997, Aust 2004, Xie 2005 |
NCOA6 | Gain (42.7) | ↑ | Lee 1999 |
PPARGC1A | Loss (8.4) | ↓ | D’Errico 2011 |
EP300 | Loss (19.3) | ↑ | Ishihama 2007 |
CREBBP | Gain (5.3) | ↑ | Ishihama 2007 |
MED1 | Gain (11.8) Loss (8.4) | ↓ | Giannini 2005 |
NCOR1 | Loss (40.4) | ↑ | Fernández-Majada 2007 |
NCOR2 | Gain (9.8) | ↑ | Giannini 2005, Fernández-Majada 2007 |
NRIP1 | Loss (17.2) | ↓ | Lapierre 2014 |
MTA1 | Loss (15.0) | ↑ | Toh 1997 |
- Citation: Triki M, Lapierre M, Cavailles V, Mokdad-Gargouri R. Expression and role of nuclear receptor coregulators in colorectal cancer. World J Gastroenterol 2017; 23(25): 4480-4490
- URL: https://www.wjgnet.com/1007-9327/full/v23/i25/4480.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i25.4480